Chemoinformaics analysis of Butyl methyl ether
| Molecular Weight | 88.15 | nRot | 3 |
| Heavy Atom Molecular Weight | 76.054 | nRig | 0 |
| Exact Molecular Weight | 88.0888 | nRing | 0 |
| Solubility: LogS | -0.936 | nHRing | 0 |
| Solubility: LogP | 1.504 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 6 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 17.1535 |
| nHD | 0 | BPOL | 13.7745 |
| QED | 0.474 |
| Synth | 1.482 |
| Natural Product Likeliness | -0.29 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.027 |
| HIA | 0.003 |
| CACO-2 | -4.09 |
| MDCK | 0.0000302 |
| BBB | 0.94 |
| PPB | 0.274814 |
| VDSS | 1.187 |
| FU | 0.719967 |
| CYP1A2-inh | 0.463 |
| CYP1A2-sub | 0.852 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.867 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.249 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.283 |
| CYP3a4-inh | 0.011 |
| CYP3a4-sub | 0.238 |
| CL | 8.356 |
| T12 | 0.672 |
| hERG | 0.035 |
| Ames | 0.009 |
| ROA | 0.086 |
| SkinSen | 0.383 |
| Carcinogencity | 0.584 |
| EI | 0.986 |
| Respiratory | 0.077 |
| NR-Aromatase | 0.007 |
| Antiviral | No |
| Prediction | 0.945833 |